FDA begins review of Eisai's AD patch

FDA accepted for review an NDA from Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) for a transdermal patch formulation of Aricept donepezil to treat Alzheimer's disease (AD). The PDUFA date is April 30, 2011...